Covid vaccine hopes rise, Oxford shot prompts immune response in old, young

  • The Oxford/AstraZeneca vaccine is expected to be one of the first from big pharma to secure regulatory approval, along with Pfizer and BioNTech's candidate
  • If it works, a vaccine would allow the world to return to some measure of normality after the tumult of the pandemic

Guy Faulconbridge, Kate Kelland and Kate Holton (with inputs from Reuters)
Updated26 Oct 2020, 05:23 PM IST
A man gets an influenza vaccine sitting inside his vehicle at a drive-thru vaccine center of a hospital.
A man gets an influenza vaccine sitting inside his vehicle at a drive-thru vaccine center of a hospital.(REUTERS)

One of the world's leading COVID-19 experimental vaccines produces a immune response in both young and old adults, raising hopes of a path out of the gloom and economic destruction wrought by the novel coronavirus.

The vaccine, developed by the University of Oxford, also triggers lower adverse responses among the elderly, British drug maker AstraZeneca Plc, which is helping manufacture the vaccine, said on Monday.

A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, shuttered swathes of the global economy and turned normal life upside down for billions of people.

"It is encouraging to see immunogenicity responses were similar between older and younger adults and that reactogenicity was lower in older adults, where the COVID-19 disease severity is higher," an AstraZeneca spokesman said.

"The results further build the body of evidence for the safety and immunogenicity of AZD1222," the spokesman said, referring to the technical name of the vaccine.

The Oxford/AstraZeneca vaccine is expected to be one of the first from big pharma to secure regulatory approval, along with Pfizer and BioNTech's candidate, as the world tries to plot a path out of the COVID-19 pandemic.

The news that older people get an immune response from the vaccine is positive because the immune system weakens with age and older people are those most at risk of dying from the virus.

If it works, a vaccine would allow the world to return to some measure of normality after the tumult of the pandemic.

British Health Secretary Matt Hancock said a vaccine was not yet ready but he was preparing logistics for a possible roll out mostly in the first half of 2021.

Asked if some people could receive a vaccine this year he told the BBC: "I don't rule that out but that is not my central expectation."

"The programme is progressing well, (but) we're not there yet," Hancock said.

Common cold virus

Work began on the Oxford vaccine in January. Called AZD1222 or ChAdOx1 nCoV-19, the viral vector vaccine is made from a weakened version of a common cold virus that causes infections in chimpanzees.

The chimpanzee cold virus has been genetically changed to include the genetic sequence of the so-called spike protein which the coronavirus uses to gain entry to human cells. The hope is that the human body will then attack the novel coronavirus if it sees it again.

Immunogenicity blood tests carried out on a subset of older participants echo data released in July which showed the vaccine generated "robust immune responses" in a group of healthy adults aged between 18 and 55, the Financial Times reported earlier.

Details of the finding are expected to be published shortly in a clinical journal, the FT said. It did not name the publication.

People aware of the results from so-called immunogenicity blood tests carried out on a subset of older participants say the findings echo data released in July that showed the vaccine generated "robust immune responses" in a group of healthy adults aged between 18 and 55.

AstraZeneca has signed several supply and manufacturing deals with companies and governments around the world as it gets closer to reporting early results of a late-stage clinical trial.

It resumed the U.S. trial of the experimental vaccine after approval by U.S. regulators, the company said on Friday.

Staff at a London hospital trust have been told to be ready to receive the first batches of the Oxford/AstraZeneca vaccine, The Sun newspaper reported on Monday.

Catch all the Business News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:26 Oct 2020, 05:23 PM IST
Business NewsNewsWorldCovid vaccine hopes rise, Oxford shot prompts immune response in old, young

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    Axis Bank share price

    1,181.30
    03:29 PM | 4 OCT 2024
    5.85 (0.5%)

    Tata Steel share price

    166.75
    03:56 PM | 4 OCT 2024
    -0.2 (-0.12%)

    Oil & Natural Gas Corporation share price

    295.20
    03:58 PM | 4 OCT 2024
    3.1 (1.06%)

    Tata Motors share price

    930.70
    03:56 PM | 4 OCT 2024
    4.7 (0.51%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    Mahindra & Mahindra Financial share price

    301.65
    03:29 PM | 4 OCT 2024
    -20.5 (-6.36%)

    Kfin Technologies share price

    1,015.00
    03:29 PM | 4 OCT 2024
    -63.85 (-5.92%)

    Godrej Properties share price

    2,897.70
    03:57 PM | 4 OCT 2024
    -170.55 (-5.56%)

    Adani Energy Solutions share price

    963.45
    03:58 PM | 4 OCT 2024
    -52.75 (-5.19%)
    More from Top Losers

    VIP Industries share price

    563.85
    03:57 PM | 4 OCT 2024
    40.8 (7.8%)

    Oil India share price

    572.25
    03:59 PM | 4 OCT 2024
    33.4 (6.2%)

    JK Paper share price

    489.95
    03:43 PM | 4 OCT 2024
    27.1 (5.86%)

    Home First Finance Company India share price

    1,245.35
    03:40 PM | 4 OCT 2024
    63.15 (5.34%)
    More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      77,695.00120.00
      Chennai
      77,701.00120.00
      Delhi
      77,853.00120.00
      Kolkata
      77,705.00120.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.86/L0.00
      Chennai
      100.85/L-0.03
      Kolkata
      104.95/L0.00
      New Delhi
      94.72/L0.00

      Popular in News

        HomeMarketsPremiumInstant LoanMint Shorts